Heart Failure in Africa, Asia, the Middle East and South America: The INTER-CHF study
Key result
African and Asian HF patients have lower health insurance and beta-blocker use than other regions.
Population
Heart failure (HF) patients from Africa, Asia, the Middle East and South America
Design
Cohort
Authors
Discussion
Loading...
Member takes
Implication
Supports targeted insurance and beta-blocker improvements for HF patients in Africa and Asia; leaves open causal effects on outcomes.
Key Points
- The study aims to assess the differences in socioeconomic and clinical factors affecting heart failure patients across different regions.
- Analysis of heart failure patients' data from Africa, Asia, the Middle East, and South America.
- Comparison of treatment options and clinical outcomes among regions.
- Evaluation of healthcare access and medication insurance rates.
- Significant variations in socioeconomic status and clinical factors among heart failure patients across regions.
- Low rates of beta blocker usage, particularly pronounced in Africa and Asia.
- Identified opportunities for improving medication insurance coverage.
Structured PICO
P
Population
Heart failure (HF) patients from Africa, Asia, the Middle East and South America
The study highlights significant regional disparities in heart failure etiologies, treatments, and socioeconomic factors across multiple continents, emphasizing the need for improved beta-blocker utilization and insurance coverage in Africa and Asia.
Cite This Study
Dokainish et al. (2015) studied this question. HF patients in Africa and Asia see opportunities for improvement in health insurance rates and beta blocker usage compared to other regions.